For the twelve months ended Sep 30, 2026, RXO Inc. reported $6.54B of revenue and -$88.00M of net income.
RXO revenueQ3 2026$1.87B
- Quarter YoY
- +31.7%
- QoQ
- +5.5%
- FY YoY
- +26.2%
- 5Y CAGR
- +11.3%
RXO revenue was $1.87B in fiscal Q3 2026 (ended Sep 30, 2026), up 31.7% from a year earlier and up 5.5% from the prior quarter. For the full fiscal 2025 it was $5.74B, up 26.2% from fiscal 2024. Compound annual growth was +11.3% over 5 years. It rose in 4 of the last 5 fiscal years. Fiscal 2025 is the highest of the 6 fiscal years on file.
RXO net incomeQ3 2026$3.00M
RXO net income was $3.00M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$14.00M a year earlier. For the full fiscal 2025 it was -$100.00M, compared with -$290.00M in fiscal 2024.
RXO EPSQ3 2026$0.02
RXO diluted EPS was $0.02 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.08 a year earlier. For the full fiscal 2025 it was -$0.59, compared with -$2.17 in fiscal 2024.
RXO free cash flowQ3 2026$12.00M
- Quarter YoY
- +33.3%
RXO free cash flow was $12.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 33.3% from a year earlier. For the full fiscal 2025 it was -$8.00M, compared with -$57.00M in fiscal 2024.
Source: XBRL data RXO Inc. files with the SEC, latest filing dated Oct 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.